Skip to content
The Nexus
DossierENTITY

Will Stone

Coverage of Will Stone in the Nexus archive.

Earliest in view: May 11 · 08:42 UTCMost recent: May 11 · 08:42 UTC
Co-mentioned in this coverage
NAD+topic1Carmel Wrothperson1
Recent coverage
  • HEALTHMay 11 · 08:42 UTCNPR HEALTH
    Does NAD+ live up the hype?

    Wellness and longevity influencers are promoting NAD+, but researchers claim marketing claims exceed scientific evidence. The compound has legitimate scientific interest in its potential. Researchers are cautious about the hype surrounding NAD+.

Will Stone · Dossier · The Nexus